Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 6
2016 4
2017 4
2018 9
2019 9
2020 11
2021 13
2022 8
2023 13
2024 17
2025 17
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Reviewing the Regulators of COL1A1.
Devos H, Zoidakis J, Roubelakis MG, Latosinska A, Vlahou A. Devos H, et al. Among authors: latosinska a. Int J Mol Sci. 2023 Jun 11;24(12):10004. doi: 10.3390/ijms241210004. Int J Mol Sci. 2023. PMID: 37373151 Free PMC article. Review.
Repurposing Amiodarone for Bladder Cancer Treatment.
Roa FJ, Roubelakis M, Paschidis K, van Creij NCH, Handle F, Makridakis M, Narayanasamy S, Balaur IA, Tserga A, Vlahou A, Santer FR, Holm PS, Hoffmann M, Puhr M, Mokou M, Frantzi M, Schneider R, Latosinska A, Mischak H, Satagopam V, Culig Z, Pichler R. Roa FJ, et al. Among authors: latosinska a. Cancer Res Commun. 2025 Jun 1;5(6):906-920. doi: 10.1158/2767-9764.CRC-24-0433. Cancer Res Commun. 2025. PMID: 40353763 Free PMC article.
In silico prediction of optimal multifactorial intervention in chronic kidney disease.
Latosinska A, Mina IK, Nguyen TMN, Golovko I, Keller F, Mayer G, Rossing P, Staessen JA, Delles C, Beige J, Glorieux G, Clark AL, Schanstra JP, Vlahou A, Peter K, Rychlík I, Ortiz A, Campbell A, Rupprecht H, Persson F, Mischak H, Siwy J. Latosinska A, et al. J Transl Med. 2025 Aug 21;23(1):943. doi: 10.1186/s12967-025-06977-3. J Transl Med. 2025. PMID: 40842026 Free PMC article.
Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination.
Frantzi M, Culig Z, Heidegger I, Mokou M, Latosinska A, Roesch MC, Merseburger AS, Makridakis M, Vlahou A, Blanca-Pedregosa A, Carrasco-Valiente J, Mischak H, Gomez-Gomez E. Frantzi M, et al. Among authors: latosinska a. Cancers (Basel). 2023 Feb 11;15(4):1166. doi: 10.3390/cancers15041166. Cancers (Basel). 2023. PMID: 36831508 Free PMC article.
Proteomics and Metabolomics for AKI Diagnosis.
Marx D, Metzger J, Pejchinovski M, Gil RB, Frantzi M, Latosinska A, Belczacka I, Heinzmann SS, Husi H, Zoidakis J, Klingele M, Herget-Rosenthal S. Marx D, et al. Among authors: latosinska a. Semin Nephrol. 2018 Jan;38(1):63-87. doi: 10.1016/j.semnephrol.2017.09.007. Semin Nephrol. 2018. PMID: 29291763 Review.
Drug repurposing in oncology.
Frantzi M, Latosinska A, Mokou M, Mischak H, Vlahou A. Frantzi M, et al. Among authors: latosinska a. Lancet Oncol. 2020 Dec;21(12):e543. doi: 10.1016/S1470-2045(20)30610-0. Lancet Oncol. 2020. PMID: 33271100 No abstract available.
Proteomic characterization of obesity-related nephropathy.
Wendt R, He T, Latosinska A, Siwy J, Mischak H, Beige J. Wendt R, et al. Among authors: latosinska a. Clin Kidney J. 2020 Apr 15;13(4):684-692. doi: 10.1093/ckj/sfaa016. eCollection 2020 Aug. Clin Kidney J. 2020. PMID: 32905225 Free PMC article.
Proteomics in Drug Development: The Dawn of a New Era?
Frantzi M, Latosinska A, Mischak H. Frantzi M, et al. Among authors: latosinska a. Proteomics Clin Appl. 2019 Mar;13(2):e1800087. doi: 10.1002/prca.201800087. Epub 2019 Feb 25. Proteomics Clin Appl. 2019. PMID: 30724014 Review.
102 results